Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Pancreatic Cancer Action Network-AACR Grantee Discussion

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Deactivating the innate immune defense mechanism of pancreatic cancer
Kian-Huat Lim
Washington Univ. School of Medicine, McDonnell Genome Institute, St Louis, MO, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:00 AM-12:30 PM
Targeting downstream effectors of KRAS via MEK and CDK-4 inhibition in PDAC
Michael N. Vansaun
Univ. of Miami, Miami, FL, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:00 AM-12:30 PM
Use of PARP1 inhibitors to leverage a tumor-selective ‘kiss of death’
David A Boothman
Indiana University School of Medicine, Indianapolis, IN, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:00 AM-12:30 PM
Clinical development of a tumor-penetrating peptide for enhanced pancreatic cancer therapy
Kazuki Sugahara
Columbia University, Herbert Irving Comprehensive Cancer Center, New York, NY, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:00 AM-12:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4